This research is focused on assessing the relationship between the variability of the blood flow through the blood vessels supplying the brain, and the risk of stroke in patients who have already had a stroke or “mini-stroke” (TIA) in the past.
Co-funded by the Stroke Association, a new review of the research into NIBS (non-invasive brain stimulation) for the recovery of leg movement and walking suggests that although it can bring about changes in leg function, the design of existing studies are very different, making it difficult to determine its effectiveness.
Vascular dementia is the 2nd leading cause of dementia in the UK and there are currently no proven treatments. A new study at the University of Southampton is now investigating whether a failure of fluid drainage along the walls of blood vessels in the brain is a cause of vascular dementia.
Co-funded by the Stroke Association, and published in the International Journal of Stroke, research suggests a new tool can better predict what level of memory and thinking (cognitive) problems patients will experience after stroke, than more time consuming methods.
PRESTIGE-AF is a new multi-million Euro initiative funded by the European Commission has been set up to help prevent stroke in patients with existing conditions.
Published online first in the journal Neurology, a new study suggests that people with AF who have an ICH due to their medication have similar outcomes whether they're on a NOAC or a vitamin K antagonist drug.
Claris Diaz, 32, originally from California, now lives in Cardiff and has devoted her life to stroke research after her childhood was affected by stroke.
Can stem cells be used to reduce the damage of inflammation after stroke and promote brain repair?
This project aims to demonstrate that failure of drainage of fluid from the grey and white matter of the brain is a mechanism underlying Small Vessel Disease, a condition that affects the small blood vessels in the brain which can cause stroke and dementia.
This study will test arm training to encourage a functionally useful contribution to recovery from the side of the brain unaffected by stroke (the 'non-stroke hemisphere'), and whether this is only possible early after stroke.